MINODRONIC ACID for Osteoporosis postmenopausal: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where MINODRONIC ACID was used for Osteoporosis postmenopausal.
Most Reported Side Effects for MINODRONIC ACID
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Osteonecrosis of jaw | 26 | 18.7% | 0 | 10 |
| Atypical femur fracture | 21 | 15.1% | 0 | 11 |
| Fall | 10 | 7.2% | 1 | 7 |
| Osteomyelitis | 8 | 5.8% | 0 | 4 |
| Nausea | 7 | 5.0% | 0 | 5 |
| Decreased appetite | 6 | 4.3% | 0 | 5 |
| Dizziness | 6 | 4.3% | 0 | 6 |
| Erythema | 6 | 4.3% | 0 | 2 |
| Off label use | 6 | 4.3% | 0 | 3 |
| Spinal fracture | 6 | 4.3% | 0 | 0 |
| Bone disorder | 5 | 3.6% | 0 | 1 |
| Femur fracture | 5 | 3.6% | 0 | 4 |
| Pyrexia | 5 | 3.6% | 1 | 4 |
Other Indications for MINODRONIC ACID
Other Drugs Used for Osteoporosis postmenopausal
DENOSUMAB (18,350)
ABALOPARATIDE (7,932)
PROLIA (1,775)
ROMOSOZUMAB-AQQG (1,401)
TERIPARATIDE (263)
ALENDRONATE (262)
ZOLEDRONIC ACID (225)
ALENDRONATE\CHOLECALCIFEROL (135)
IBANDRONIC ACID (116)
ALENDRONIC ACID (105)